Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Nippon Shinyaku

    Client Virtual Booth

    NIPPON SHINYAKU

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    EXCIPIENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Nippon Shinyaku
    japan Flag
    Country
    Country
    Japan
    Address
    Address
    14, Nishinosho-Monguchi-cho, Kisshoin, Minami-ku, Kyoto 601-8550
    Telephone
    Telephone
    +81-75-321-1111
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.nippon-shinyaku.co.jp/english/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    MiNA Collaboration with Nippon to Develop RNAa Therapeutics Targeting
    MiNA Collaboration with Nippon to Develop RNAa Therapeutics Targeting

    https://www.businesswire.com/news/home/20240404146569/en

    BUSINESSWIRE
    04 Apr 2024
    Share Share
    Japanese pharma firm Eli Lilly, Nippon Shinyaku join hands haematologic oncology
    Japanese pharma firm Eli Lilly, Nippon Shinyaku join hands haematologic oncology

    https://www.biospectrumasia.com/news/25/24004/japanese-pharma-firms-eli-lilly-nippon-shinyaku-join-hands-to-strengthen-haematologic-oncology-field.html

    BIOSPECTRUM ASIA
    28 Mar 2024
    Share Share
    The Menarini Group Announces ELZONRIS Designated as an Orphan Drug for BPDCN
    The Menarini Group Announces ELZONRIS Designated as an Orphan Drug for BPDCN

    https://www.businesswire.com/news/home/20230830257431/en

    BUSINESSWIRE
    30 Aug 2023
    Share Share
    Japan approves iron deficiency drug from Pharmacosmos
    Japan approves iron deficiency drug from Pharmacosmos

    https://medwatch.com/News/Pharma___Biotech/article13868643.ece?utm_campaign=MedWatch%20Newsletter&utm_content=2022-03-28&utm_medium=email&utm_source=medwatch_com

    M.A. Hemmingsen MEDWATCH
    29 Mar 2022
    Share Share
    Nippon Shinyaku Establishes a Local Subsidiary in Tianjin, China
    Nippon Shinyaku Establishes a Local Subsidiary in Tianjin, China

    https://www.nippon-shinyaku.co.jp/file/download.php?file_id=5906

    PRESS RELEASE
    26 Jan 2022
    Share Share
    Capricor Tx, Nippon Shinyaku Partner for CAP-1002 in DMD
    Capricor Tx, Nippon Shinyaku Partner for CAP-1002 in DMD

    https://www.globenewswire.com/news-release/2022/01/25/2372202/0/en/Capricor-Therapeutics-and-Nippon-Shinyaku-Enter-Partnership-for-Exclusive-Commercialization-and-Distribution-of-CAP-1002-for-the-Treatment-of-Duchenne-Muscular-Dystrophy-in-the-U-S.html

    GLOBENEWSWIRE
    25 Jan 2022
    Share Share
    Nippon Shinyaku, Dynacure partner to develop & commercialize DYN101 in Japan
    Nippon Shinyaku, Dynacure partner to develop & commercialize DYN101 in Japan

    http://www.pharmabiz.com/NewsDetails.aspx?aid=143875&sid=2

    PHARMABIZ
    11 Nov 2021
    Share Share
    Menarini Group and Nippon Shinyaku Enter into an Exclusive License Agreement
    Menarini Group and Nippon Shinyaku Enter into an Exclusive License Agreement

    https://www.prnewswire.com/news-releases/menarini-group-and-nippon-shinyaku-enter-into-an-exclusive-license-agreement-to-develop-and-commercialize-elzonris-tagraxofusp-in-japan-301257388.html

    PRNEWSWIRE
    29 Mar 2021
    Share Share
    Nippon Shinyaku’s DMD Drug Gets Orphan Status in Europe
    Nippon Shinyaku’s DMD Drug Gets Orphan Status in Europe

    https://pj.jiho.jp/article/242295

    JIHO
    09 Jun 2020
    Share Share
    Nippon Shinyaku inks new agreement for prostate cancer treatment
    Nippon Shinyaku inks new agreement for prostate cancer treatment

    https://www.biospectrumasia.com/news/25/15419/nippon-shinyaku-inks-new-agreement-for-prostate-cancer-treatment.html

    BIOSPECTRUMASIA
    12 Feb 2020
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search